CORDIS - Forschungsergebnisse der EU
CORDIS

The role of intravesicular ATP in excitatory and inhibitory synapses of the central nervous system

Projektbeschreibung

Adenosintriphosphat als Akteur im zentralen Nervensystem

Adenosintriphosphat (ATP) ist der Energieträger aller Zellen und als solcher für viele lebende Prozesse von entscheidender Bedeutung. Das EU-finanzierte Projekt COST-ATP wird untersuchen, welche Rolle ATP in den Neurotransmittervesikeln von erregenden und hemmenden Synapsen des zentralen Nervensystems spielt. Dazu werden die Forschenden die am ATP-Transport beteiligten vesikulären Nukleotidtransporter (VNUT) manipulieren, ohne dabei den zellulären ATP-Spiegel insgesamt zu verändern. Die Entdeckung von Adenosintriphosphat als Regulator der neuronalen Übertragung eröffnet neue Wege, um neue pharmakologische Ziele für die Behandlung von neurologischen, psychiatrischen und Herz-Kreislauf-Erkrankungen zu identifizieren.

Ziel

COST-ATP pretends to establish the role of intravesicular ATP in excitatory and inhibitory synapses of the central nervous system (CNS). Although, several laboratories have characterized the crucial interaction between ATP and catecholamines to permit its large accumulation in secretory vesicles of chromaffin cells, this crucial mechanism has not been studied in synaptic vesicles where high concentrations of neurotransmitters are needed for neuronal communication in the CNS. COST-ATP will combine the experience of the host laboratory in ATP as an accumulator of neurotransmitters in chromaffin cells and the TIRFM technology, and the ample experience of the researcher in cutting edge electrophysiological techniques in hippocampal neurons. The project will use electrophysiology, TIRFM, molecular biology and pharmacological tools to first discern the packagingbrole of vesicular ATP from its actions as neurotransmitter in central synapses using autaptic cultures of mouse hippocampal neurons. COST-ATP wants to explain why ATP is present inside of synaptic vesicles of almost all neurons. The main
advantage of our approach is that we can modify the vesicular ATP by acting on the specific vesicular nucleotide carrier (VNUT) without affecting its cellular functions as the molecular energy. The consideration of the ATP, by its colligative properties, as a regulator of the neurotransmission, opens a new door in the neuronal communication. Given that its accumulation is mediated by VNUT a regulation of its activity could constitute a new pharmacological target for the treatment of neurological, psychiatric and cardiovascular diseases without involving membrane receptors.

Koordinator

UNIVERSIDAD DE LA LAGUNA
Netto-EU-Beitrag
€ 160 932,48
Adresse
PADRE HERRERA S/N
38200 SAN CRISTOBAL DE LA LAGUNA
Spanien

Auf der Karte ansehen

Region
Canarias Canarias Tenerife
Aktivitätstyp
Higher or Secondary Education Establishments
Links
Gesamtkosten
€ 160 932,48